Comparison of therapeutic responses to an anticancer drug in three stocks of ICR mice derived from three different sources.
10.5625/lar.2017.33.2.187
- Author:
Ji Eun SUNG
1
;
Ji Eun KIM
;
Hyun Ah LEE
;
Woo Bin YUN
;
Jun Young CHOI
;
Mi Rim LEE
;
Jin Ju PARK
;
Hye Ryeong KIM
;
Bo Ram SONG
;
Young Suk JUNG
;
Kil Soo KIM
;
Dae Youn HWANG
Author Information
1. Department of Biomaterials Science, College of Natural Resources & Life Science/Life and Industry Convergence Research Institute, Pusan National University, Miryang 627-706, Korea. dyhwang@pusan.ac.kr
- Publication Type:Original Article
- Keywords:
Korl:ICR mice;
tumor;
Sarcoma 180 cell;
cisplatin;
toxicity
- MeSH:
Animals;
Biomarkers;
Cisplatin;
Constipation;
Genetic Variation;
Kidney;
Liver;
Mice;
Mice, Inbred ICR*;
Sarcoma;
Sarcoma 180;
Tumor Burden
- From:Laboratory Animal Research
2017;33(2):187-194
- CountryRepublic of Korea
- Language:English
-
Abstract:
Korl:ICR mice, established by the Korean National Institute of Food and Drug Safety Evaluation (NIFDS), are characterized based on their genetic variation, response to gastric injury, and response to constipation inducers. To compare the inhibitory responses of ICR stocks obtained from three different sources to the anticancer drug cisplatin (Cis), alterations in tumor volume, histopathological structure, and toxicity were examined in Sarcoma 180 tumor-bearing Korl:ICR, A:ICR (USA source), and B:ICR (Japan source) mice treated with low and high concentrations of Cis (L-Cis and H-Cis, respectively). Tumor size and volume were lower in H-Cis-treated mice than in L-Cis-treated mice in all three ICR stocks with no significant differences among stocks. There was a significant enhancement of the necrotizing areas in the histological structures in the L-Cis- and H-Cis-treated groups relative to that in the untreated group. The necrotizing area changes were similar in the Sarcoma 180 tumor-bearing Korl:ICR, A:ICR, and B:ICR mice. However, there were stock-bases differences in the serum biomarkers for liver and kidney toxic effects. In particular, the levels of AST, ALT and BUN increased differently in the three H-Cis-treated ICR stocks, whereas the levels of ALP and CRE were constant. Taken together, the results of the present study indicate that Korl:ICR, A:ICR, and B:ICR mice have similar overall inhibitory responses following Cis treatment of Sarcoma 180-derived solid tumors, although there were some differences in the magnitude of the toxic effects in the three ICR stocks.
